Search results for "unity"

showing 10 items of 3852 documents

Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).

2011

Background: Heptavalent pneumococcal conjugate vaccine (PCV-7) was licensed to provide immunity against pneumococcal disease caused by seven serotypes of S. pneumoniae. Thirteen-valent pneumococcal conjugate vaccine (PCV-13) includes 6 additional serotypes for preventing invasive pneumococcal disease. Objective: The objective of this study was to estimate the potential health benefits, costs, and cost-effectiveness of vaccination with PCV-13 in the Community of Valencia and to generate valuable information for policy makers at regional and country levels. Methods: A decision tree was designed to determine the health and economic outcomes in hypothetical cohorts of vaccinated and unvaccinate…

AdultMalePediatricsmedicine.medical_specialtyAdolescentCost effectivenessPharmacoeconomic assessmentCost-Benefit AnalysisPneumococcal conjugate vaccinePneumococcal InfectionsHerd immunityPneumococcal VaccinesIndirect costsYoung AdultEnvironmental healthmedicineHeptavalent Pneumococcal Conjugate VaccineHumansChildAgedAged 80 and overGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPneumococcal conjugate vaccineVaccinationPublic Health Environmental and Occupational HealthInfant NewbornInfantMiddle AgedQuality-adjusted life yearVaccinationInfectious DiseasesSpainChild PreschoolCohortMolecular MedicineCost-effectivenessFemalebusinessmedicine.drugVaccine
researchProduct

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccinatio…

2009

Priming a population with a pre-pandemic vaccine is being considered to maximize the response upon subsequent vaccination with a true pandemic vaccine more closely matched to the causative pandemic strain. The present study explored this prime-boost concept by evaluating different primary schedules with the pre-pandemic A/Vietnam/1194/2004(NIBRG-14) vaccine, containing 3.75 microg of HA, followed by a 6-month booster with a vaccine formulated with 3.75 microg HA of either the same strain or with A/Indonesia/05/2005(IBCDC-RG2), a heterologous strain from a different clade. In this multicentre, open, randomized study (NCT00430521) we measured immune responses in four groups (N = 48-60) of adu…

AdultMalePediatricsmedicine.medical_specialtyAdolescentCross Protectionmedicine.medical_treatmentPopulationImmunization SecondaryBooster doseAntibodies ViralYoung AdultAdjuvants ImmunologicImmunityInfluenza Humanparasitic diseasesmedicineHumansAS03educationeducation.field_of_studyBooster (rocketry)Influenza A Virus H5N1 SubtypeGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPublic Health Environmental and Occupational HealthHemagglutination Inhibition TestsMiddle AgedImmunity HumoralVaccinationInfectious DiseasesImmunizationInfluenza VaccinesImmunologyMolecular MedicineFemalebusinessAdjuvantVaccine
researchProduct

Immunity to tetanus in the 3-20 year age group in Italy

1997

In Italy, systematic mandatory tetanus immunization of children started in 1968. In 1989, immunity against tetanus was assessed in a random sample of 758 healthy subjects aged 3-20 y, from four Italian cities. There were 257 subjects 3-5 y old all residing in Southern Italy and 501 subjects 11-20 y old from both the South and North. The overall prevalence of non-immune subjects was 19.1%, without difference by sex. The rates of subjects lacking protective antibody titres was 25.3% in children 3-5 y old (all coming from South and the islands), 11.5% in those 11 y old, and 18.9% in the 18-20 y age-group, respectively. Subjects 11-20 y old residing in the South and the islands were more likely…

AdultMalePediatricsmedicine.medical_specialtyAdolescentTetanus immunizationTetanus.ImmunitymedicinePrevalenceTetanus ToxoidHumansChildHigh rateTetanusTetanusbusiness.industryPublic Health Environmental and Occupational HealthHealthy subjectsImmunityGeneral Medicinemedicine.diseaseAntibodies BacterialVaccinationItalyChild PreschoolFemaleProtective antibodyGeographical inequalitiesbusiness
researchProduct

The association between diabetes and cataract among 42,469 community-dwelling adults in six low- and middle-income countries

2018

Background: Cataract is a major cause of visual impairment in people with diabetes, yet a paucity of data is available in low- and middle-income countries (LMICs) on this comorbidity. Thus we assessed the association between diabetes and cataract in 6 LMICs. Methods: Cross-sectional, community-based data from the Study on Global Ageing and Adult Health (SAGE) was analyzed (n = 42,469 aged ≥18 years). Five years information on self-reported diagnosis of cataract was collected. Three definitions for cataract were used: (a) Self-reported diagnosis and/or past 12-month symptoms; (b) Solely self-reported diagnosis; and (c) Surgical treatment for cataract in the past five years. Diabetes was base…

AdultMalePediatricsmedicine.medical_specialtyEndocrinology Diabetes and MetabolismVisual impairment030209 endocrinology & metabolismcataract diabetesLogistic regressionCataractDiabetes Complications03 medical and health sciences0302 clinical medicineEndocrinologyQuality of lifeDiabetes mellitusCommunity-basedInternal MedicinemedicineHumans030212 general & internal medicineSurgical treatmentPovertyLow- and middle-income countriesbusiness.industryDiabetesTreatment optionsGeneral Medicinemedicine.diseaseComorbidityCross-Sectional StudiesSocial ClassLow and middle income countriesQuality of LifeFemaleIndependent Livingmedicine.symptombusinessDiabetes Research and Clinical Practice
researchProduct

Migraine history and migraine-induced stroke in the Dijon stroke registry.

1999

Two thousand three hundred and eighty-nine patients with first-ever stroke were registered in the population-based Dijon Stroke Registry over an 11-year period. There was a history of migraine in 49 cases (2%), with a majority of women (2.8% versus 1.1% men) with the following distribution: 27 cases among 1,380 large-artery cerebral infarctions (1.9%), 6 cases among 358 small-artery cerebral infarctions (1.6%), 6 cases among 412 cerebral infarctions due to cardiac embolism (1.4%), 7 cases among 191 cerebral hemorrhages (3.6%) and 3 cases among 47 subarachnoid hemorrhages (6.3%). The male/female ratio was 0.58 for the 49 strokes with a history of migraine versus 1.27 for the 2,340 strokes wi…

AdultMalePediatricsmedicine.medical_specialtyStroke registryAdolescentEpidemiologyMigraine DisordersPopulationInfarctionCatchment Area HealthRecurrenceRisk FactorsEpidemiologyMedicineHumanscardiovascular diseasesProspective StudiesRegistrieseducationStrokeeducation.field_of_studybusiness.industryIncidence (epidemiology)Middle Agedmedicine.diseaseConfidence intervalCerebrovascular DisordersMigraineCommunity MedicineAnesthesiaPopulation SurveillanceFemaleNeurology (clinical)FrancebusinessNeuroepidemiology
researchProduct

Immunologic findings in workers formerly exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners

1998

One hundred ninety-two workers in a German pesticide factory who were exposed to polychlorinated dibenzodioxins and -furans (PCDD/PCDF) were investigated for former and present diseases and laboratory changes of the immune system. Moreover, in a subgroup of 29 highly exposed and 28 control persons, proliferation studies were performed. In addition to assays such as blood count, immunoglobulins, serum electrophoresis, monoclonal bands, surface markers, autoantibodies, and lymphocyte proliferation, two new methods, the rise of tetanus antibody concentration after vaccination and the in vitro resistance of lymphocytes to chromate, were used to diagnose the morphologic and functional state of t…

AdultMalePolychlorinated DibenzodioxinsHealth Toxicology and MutagenesisPolychlorinated dibenzodioxinsLymphocyte proliferationLymphocyte ActivationCohort Studieschemistry.chemical_compoundImmune systemImmunityOccupational ExposuremedicineChromatesTetanus ToxoidHumansPesticidesPhytohemagglutininsFuransAgedImmunity CellularbiologyTetanusPublic Health Environmental and Occupational HealthAutoantibodyMiddle Agedmedicine.diseaseVaccinationchemistryChemical IndustryImmunologyAntibody Formationbiology.proteinFemaleAntibodyResearch Article
researchProduct

Perception of the professional nursing environment in Primary Care in the Valencian Community, in departments with public and private management

2019

Resumen Fundamento Los entornos para la práctica profesional enfermera (EPE) mejoran la calidad del cuidado, la satisfacción y los resultados en salud, no existiendo ninguna medición en Atención Primaria (AP) según su modelo de gestión. Pretendemos estimar y comparar la percepción de la calidad de dichos ERE en AP en tres departamentos de salud (DS) de la Comunidad Valenciana con modelos de gestión pública y privada (concesión administrativa). Material y métodos Estudio transversal en profesionales de Enfermería de AP de tres DS, uno de gestión pública y dos de gestión privada. Se utilizó el cuestionario Practice Environment Scale-Nursing Work Index validado en España y se recogieron variab…

AdultMalePrimary health careNursesNursing work environmentPublic-Private Sector PartnershipsModelos de gestiónValencian communityAsociaciones entre el sector público y el privadoPublic-private sector partnerships03 medical and health sciences0302 clinical medicineManagement modelNursingSurveys and QuestionnairesPublic managementHumans030212 general & internal medicineQuality of careQuality of Health CareNursing practiceEntornos de práctica enfermeraPrimary Care NursingPrimary Health CareAge FactorsManagement modelAtención PrimariaGeneral MedicineMiddle AgedPrimary careCross-Sectional StudiesSpainModels OrganizationalTest scoreQuality of health careFemalePsychologyCalidad de la atención de salud
researchProduct

Can CAP guideline adherence improve patient outcome in internal medicine departments?

2008

The impact of compliance with Italian guidelines on the outcome of hospitallised community-acquired pneumonia (CAP) in internal medicine departments was evaluated. All Fine class IV or V CAP patients were included in this multicentre, interventional, before-and-after study, composed of three phases: 1) a retrospective phase (RP; 1,443 patients); 2) a guideline implementation phase; and 3) a prospective phase (PP; 1,404 patients). Antibiotic prescription according to the guidelines increased significantly in the PP. The risk of failure at the end of the firstline therapy was significantly lower in the PP versus the RP (odds ratio (OR) 0.83, 95% confidence interval (CI) 0.69-1.00), particular…

AdultMalePulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtycommunity acquired-pneumonia guideline internal medicineadherenceCritical Caremedicine.drug_classAntibioticsPopulationCommunity-acquired pneumoniaLevofloxacinInternal medicineInternal MedicinemedicineHumansProspective StudieseducationAgedRetrospective StudiesAged 80 and overeducation.field_of_studybusiness.industryPneumoniaOdds ratioGuidelineMiddle Agedmedicine.diseaseConfidence intervalCommunity-Acquired InfectionsPneumoniaTreatment OutcomeItalyFemaleGuideline Adherencebusinessmedicine.drugEuropean Respiratory Journal
researchProduct

Is it possible to predict which patients with mild pneumonias will develop hypoxemia?

2009

SummaryUsually, mortality due to mild community-acquired pneumonias (CAP) (Pneumonia severity index (PSI) classes I–III) is low (<3%), but the appearance of hypoxemia significantly increases mortality. Our aim was to determine the clinical parameters associated with risk factors of developing hypoxemia in subjects with mild CAP (PSI I–III) and the clinical outcomes of the hypoxemic group.We analyzed clinical characteristics and the outcomes of patients with mild CAP and hypoxemia (PaO2/FiO2<300), in a prospective, multicenter cohort study of 1195 patients.Mild pneumonias (PSI I–III) were found in 645 cases (53.9%), of which 217 (33.6%) presented hypoxemia according to a PaO2/FiO2<300. Patie…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyAdolescentCommunity-acquired pneumoniamedicine.medical_treatmentPneumonia severity indexSeverity assessmentHypoxemiaHypoxemiaPulmonary Disease Chronic ObstructiveYoung AdultCommunity-acquired pneumoniaHumansMedicineHypoalbuminemiaHypoxiaAgedMechanical ventilationCOPDbusiness.industrySeptic shockPneumoniaMiddle Agedmedicine.diseaserespiratory tract diseasesSurgeryCommunity-Acquired InfectionsRadiographyPneumoniaRisk factorsAnesthesiaFemalemedicine.symptomEpidemiologic MethodsbusinessHypoalbuminemiacirculatory and respiratory physiologyRespiratory Medicine
researchProduct

Do childhood respiratory infections continue to influence adult respiratory morbidity?

2008

The aim of the present study was to examine the influence of childhood respiratory infections on adult respiratory health. In 1992-1994, the European Community Respiratory Health Survey recruited community based samples of 20-44-yr-old people from 48 centres in 22 countries. Study participants completed questionnaires and underwent lung function testing. On average, 8.9 yrs later, 29 centres re-investigated their samples using similar methods. Mixed effects models comprising an estimate for the random variation between centres were used to evaluate the relevant associations. In total, 9,175 patients participated in both studies, of whom 10.9% reported serious respiratory infections (SRI) be…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyVital capacityCohort StudiesFEV1/FVC ratioSurveys and QuestionnairesInternal medicineWheezeOdds RatioPrevalenceHumansMedicineCommunity Health ServicesRespiratory soundsAge of OnsetIntensive care medicineRespiratory Tract InfectionsRespiratory SoundsAsthmaRespiratory tract infectionsmedicine.diagnostic_testbusiness.industrySmokingRespiratory diseaseOdds ratiomedicine.diseaseAsthmaChild PreschoolFemalemedicine.symptombusinessEuropean Respiratory Journal
researchProduct